Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis

Journal of Infection

Volumn 72, Issue 1, 2016, Pages 19-28

  Vogel, Monique ^a   Schmitz, Roland P H ^a   Hagel, Stefan ^a   Pletz, Mathias W ^a   Gagelmann, Nico ^a   Scherag, André ^a   Schlattmann, Peter ^a   Brunkhorst, Frank M ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Bacteremia; Infectious disease medicine; Meta analysis; Mortality; Quality of health care; Staphylococcus aureus

Indexed keywords

AGED; BACTEREMIA; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; PATIENT REFERRAL; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS AND NUMERICAL DATA;

AGED; BACTEREMIA; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; REFERRAL AND CONSULTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84955378101     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.09.037     Document Type: Article

References (47)

1. ECDC. European Centre for Disease Prevention and Control Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2013, ECDC, Stockholm.
2. Kaasch A.J., Barlow G., Edgeworth J.D., Fowler V.G., Hellmich M., Hopkins S., et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect 2014, 68(3):242-251.
3. Laupland K.B., Lyytikainen O., Sogaard M., Kennedy K.J., Knudsen J.D., Ostergaard C., et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect 2013, 19(5):465-471.
4. Liu C. Editorial commentary: a quality-of-care bundle for treatment of Staphylococcus aureus bacteremia: ready for prime time?. Clin Infect Dis 2013, 57(9):1234-1236.
5. Lundberg J., Nettleman M.D., Costigan M., Bentler S., Dawson J., Wenzel R.P. Staphylococcus aureus bacteremia: the cost-effectiveness of long-term therapy associated with infectious diseases consultation. Clin Perform Qual Health Care 1998, 6(1):9-11.
6. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36(1):53-59.
7. Schmitt S., McQuillen D.P., Nahass R., Martinelli L., Rubin M., Schwebke K., et al. Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs. Clin Infect Dis 2014, 58(1):22-28.
8. Tong S.Y., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015, 28(3):603-661.
9. Smetana G.W., Landon B.E., Bindman A.B., Burstin H., Davis R.B., Tjia J., et al. A comparison of outcomes resulting from generalist vs specialist care for a single discrete medical condition: a systematic review and methodologic critique. Arch Intern Med 2007, 167(1):10-20.
10. Fowler V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27(3):478-486.
11. Holland T.L., Arnold C., Fowler V.G. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 2014, 312(13):1330-1341.
12. Kim A.I., Adal K.A., Schmitt S.K. Staphylococcus aureus bacteremia: using echocardiography to guide length of therapy. Cleve Clin J Med 2003, 70(6):517. 20-1, 25-6 passim.
13. Lodise T.P., McKinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36(11):1418-1423.
14. Pulcini C., Botelho-Nevers E., Dyar O.J., Harbarth S. The impact of infectious disease specialists on antibiotic prescribing in hospitals. Clin Microbiol Infect 2014, 20(10):963-972.
15. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097.
16. Lopez-Cortes L.E., Del Toro M.D., Galvez-Acebal J., Bereciartua-Bastarrica E., Farinas M.C., Sanz-Franco M., et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013, 57(9):1225-1233.
17. Sanderson S., Tatt I.D., Higgins J.P. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007, 36(3):666-676.
18. Guyatt G.H., Oxman A.D., Vist G., Kunz R., Brozek J., Alonso-Coello P., et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 2011, 64(4):407-415.
19. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
20. Schwarzer G. Meta: meta-analysis with R. R package version 31-22013.
21. Riley R.D., Higgins J.P., Deeks J.J. Interpretation of random effects meta-analyses. BMJ 2011, 342:d549.
22. Bai A.D., Showler A., Burry L., Steinberg M., Ricciuto D.R., Fernandes T., et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis 2015, 60(10):1451-1461.
23. Borde J.P., Batin N., Rieg S., Feik R., Reimling C., Kern W.V., et al. Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital. Infection 2014, 42(4):713-719.
24. Choi S.H., Cho S.Y., Park J.H., Chung J.W. Impact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia. J Infect 2011, 62(2):181-185.
25. Forsblom E., Ruotsalainen E., Ollgren J., Jarvinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2013, 56(4):527-535.
26. Fries B.L., Licitra C., Crespo A., Akhter K., Busowski M.T., Salazar D., et al. Infectious diseases consultation and the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2014, 58(4):598-599.
27. Honda H., Krauss M.J., Jones J.C., Olsen M.A., Warren D.K. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010, 123(7):631-637.
28. Isobe M., Uejima E., Seki M., Yamagishi Y., Miyawaki K., Yabuno K., et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother 2012, 18(6):841-847.
29. Jenkins T.C., Price C.S., Sabel A.L., Mehler P.S., Burman W.J. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008, 46(7):1000-1008.
30. Jogenfors A., Stark L., Svefors J., Lofgren S., Malmvall B.E., Matussek A. A recommendation to perform a blood culture before the administration of intravenous antibiotics increased the detection of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2014, 33(5):789-795.
31. Lahey T., Shah R., Gittzus J., Schwartzman J., Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Med (Baltimore) 2009, 88(5):263-267.
32. Nagao M., Iinuma Y., Saito T., Matsumura Y., Shirano M., Matsushima A., et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010, 16(12):1783-1788.
33. Pragman A.A., Kuskowski M.A., Abraham J.M., Filice G.A. Infectious disease consultation for Staphylococcus aureus bacteremia improves patient management and outcomes. Infect Dis Clin Pract (Baltim Md) 2012, 20(4):261-267.
34. Rieg S., Peyerl-Hoffmann G., de With K., Theilacker C., Wagner D., Hubner J., et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009, 59(4):232-239.
35. Robinson J.O., Pozzi-Langhi S., Phillips M., Pearson J.C., Christiansen K.J., Coombs G.W., et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012, 31(9):2421-2428.
36. Saunderson R.B., Gouliouris T., Cartwright E.J., Nickerson E.J., Aliyu S.H., O'Donnell D.R., et al. Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children. BMJ Open 2014, 4(7):e004659.
37. Tissot F., Calandra T., Prod'hom G., Taffe P., Zanetti G., Greub G., et al. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. J Infect 2014, 69(3):226-234.
38. Saunderson R.B., Gouliouris T., Nickerson E.K., Cartwright E.J., Kidney A., Aliyu S.H., et al. Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults. Clin Microbiol Infect 2015, 21(8):779-785.
39. McKendrick M.W. The European Union of Medical Specialties core training curriculum in infectious diseases: overview of national systems and distribution of specialists. Clin Microbiol Infect 2005, 11(Suppl 1):28-32.
40. Chu V.H., Sexton D.J. Editorial commentary: telephone consultation for Staphylococcus aureus bacteremia: opening Pandora's box. Clin Infect Dis 2013, 56(4):536-538.
41. Read R.C., Cornaglia G., Kahlmeter G. Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. Lancet Infect Dis 2011, 11(5):408-415.
42. Schweizer M.L., Furuno J.P., Harris A.D., Johnson J.K., Shardell M.D., McGregor J.C., et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011, 11:279.
43. Kim S.H., Kim K.H., Kim H.B., Kim N.J., Kim E.C., Oh M.D., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008, 52(1):192-197.
44. Rasmussen J.B., Knudsen J.D., Arpi M., Schonheyder H.C., Benfield T., Ostergaard C. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study. J Antimicrob Chemother 2014, 69(2):506-514.
45. Nissen J.L., Skov R., Knudsen J.D., Ostergaard C., Schonheyder H.C., Frimodt-Moller N., et al. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis. J Antimicrob Chemother 2013, 68(8):1894-1900.
46. Bai A.D., Showler A., Burry L., Steinberg M., Ricciuto D.R., Fernandes T., et al. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother 2015, 70(5):1539-1546.
47. Liu C., Bayer A., Cosgrove S.E., Daum R.S., Fridkin S.K., Gorwitz R.J., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011, 52(3):285-292.